Potential Use of Cellular Stromal Vascular Fraction in Post-COVID-19 Injury and Respiratory Distress
Posted in Clinical Trials & Pilot Studies, Ideas & Innovations
June 2nd, 2020 SDARTs faculty member, Robert W. Alexander, MD, DDS, is the Principle Investigator on a first-in-human clinical trial to treat post-COVID 19 survivors with AD cSVF. Many moderate to severe post-COVID 19 survivors experience compromised lung function. As a proposed solution, adipose-derived cellular stromal vascular fraction (AD cSVF) may be effective in reversing […]
Read More